Financial Planning Hawaii Inc. bought a new stake in Aflac Incorporated (NYSE:AFL – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 7,632 shares of the financial services provider’s stock, valued at approximately $842,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. True Wealth Design LLC increased its position in Aflac by 188.5% in the third quarter. True Wealth Design LLC now owns 225 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 147 shares during the period. Darwin Wealth Management LLC acquired a new position in Aflac during the 2nd quarter valued at about $33,000. Westside Investment Management Inc. boosted its stake in shares of Aflac by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 324 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 162 shares during the last quarter. JCIC Asset Management Inc. bought a new position in shares of Aflac in the 3rd quarter valued at about $45,000. Finally, Board of the Pension Protection Fund acquired a new stake in shares of Aflac during the 4th quarter worth approximately $44,000. Institutional investors own 67.44% of the company’s stock.
Aflac Stock Up 1.5%
Aflac stock opened at $108.05 on Tuesday. The firm has a market capitalization of $55.67 billion, a price-to-earnings ratio of 15.71, a PEG ratio of 3.49 and a beta of 0.66. The company’s 50 day simple moving average is $111.10 and its 200 day simple moving average is $110.38. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.11 and a quick ratio of 0.11. Aflac Incorporated has a fifty-two week low of $96.95 and a fifty-two week high of $119.32.
Insiders Place Their Bets
In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 14,200 shares of the business’s stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of $107.03, for a total value of $1,519,826.00. Following the completion of the transaction, the insider directly owned 52,018,600 shares of the company’s stock, valued at approximately $5,567,550,758. The trade was a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles D. Lake II sold 15,590 shares of the stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $109.93, for a total value of $1,713,808.70. Following the completion of the sale, the director owned 62,237 shares of the company’s stock, valued at $6,841,713.41. This trade represents a 20.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 235,077 shares of company stock valued at $25,690,082. 0.80% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. Morgan Stanley set a $120.00 price objective on shares of Aflac in a report on Monday, December 15th. Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a report on Saturday, February 28th. Raymond James Financial reiterated an “outperform” rating and set a $119.00 target price (up from $110.00) on shares of Aflac in a research report on Tuesday, December 30th. Barclays set a $101.00 price target on Aflac and gave the company an “underweight” rating in a research note on Thursday, January 8th. Finally, JPMorgan Chase & Co. lifted their price objective on Aflac from $101.00 to $105.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $112.00.
Get Our Latest Research Report on Aflac
Aflac Profile
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Featured Stories
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
